Document is current
Any future updates will be listed below
-
Authors
Rodriguez-Freixinos, Victor
Thawer, Alia
Capdevila, Jaume
Ferone, Diego
Singh, Simron
- License Information
-
More Information
Article History
Accepted: 31 March 2021
First Online: 3 May 2021
Declarations
:
: Victor Rodriguez-Freixinos and Diego Ferone declare no conflict of interest. Alia Thawer has received research funding from Novartis (Melanoma Guideline) and AstraZeneca (local quality improvement work); has received speaker’s honoraria from Novartis (NET allied health education and melanoma education) and Pfizer (breast allied health education); and has received compensation from AbbVie for service as a consultant. Jaume Capdevila has received research funding from Novartis, Pfizer, Bayer, Eisai, Advanced Accelerator Applications, and AstraZeneca; and has received compensation from Novartis, Pfizer, Ipsen, Exelixis, Bayer, Eisai, Advanced Accelerator Applications, Eli Lilly, Sanofi, and Merck Serono for service as a consultant. Simron Singh has received research funding/fellowship support from Pfizer, and has received compensation from Ipsen and Novartis for service as a consultant.
: This article does not contain any studies with human or animal subjects performed by the authors.
